Syntax Bio

Syntax is redefining cell therapy manufacturing with its novel CRISPR-based platform, Cellgorithm. Inspired by developmental biology, Cellgorithm enables automated, step-wise gene regulation to guide induced pluripotent stem cells (iPSCs) through specific lineages. This approach allows for the generation of therapeutic cell types that traditional transcription factor-based methods cannot achieve. Proof-of-concept has been demonstrated across multiple cell types, positioning Syntax at the forefront of next-generation regenerative medicine.